IL6 and breast cancer: High IL-6 expression was significantly associated with DFS in non-basal (P = 0.004), non-TN disease (P = 0.003), ER-positive (P = 0.025), and Her-2-negative (P = 0.026) BC (Supplementary Fig. 1a–d, respectively).